Thomas Richardson

Thomas Richardson is a Senior Biomaterials Engineer at Pear Bio, where responsibilities include developing 3D cell culture architectures for testing cancer therapies and planning the validation of a confocal-microscopy-based in vitro assay. Prior experience includes roles at Engitix Therapeutics, focusing on hydrogel scaffolds for liver fibrosis models, and as a Clinical Lab Scientist at Pear Bio, contributing to clinical trial programs and microfluidic chip research. Educational qualifications include a PhD in Functional Nanomaterials and a Master's in Bionanotechnology from the University of Bristol and University of Leeds, respectively, complemented by a Bachelor’s in Nanotechnology and the International Baccalaureate from Awty International School.